Search results for: Multi-Indication Medicines
Filter search results
OHE Annual Lecture 2019: The Evolution of U.S. Policy Responses to the Opioid Epidemic
14 October 2019, 11:00pm
…been multifaceted, including efforts aimed at prevention, treatment and harm reduction. The policy response in the form of spending patterns, regulation, and law enforcement has been heterogeneous in focus, uneven…
OHE at ISPOR’s 20th Annual European Congress in Glasgow
2 November 2017
…both theory and practice, including several examples of performance-based schemes from Europe, the United States, and Australia. 13:00-17:00: Using multi-criteria decision analysis in health care decision making: approaches & applications….
“You Don’t Always Get What You Want”: Output Distortion and NHS Waiting Time Targets
18 December 2018
…organisations have multiple objectives and even within a single objective (e.g. delivering high-quality care) there are multiple dimensions to be considered. However, as Drucker (1974) stated, “what gets measured gets…
Exploring Variations in the Opportunity Cost Cost-effectiveness Threshold by Clinical Area: Results from a Feasibility Study in England
20 March 2019
…incorporation of multiple outcomes (not just mortality) and the measurement of efficiency and scale elasticity, while QR allows us to look for non-linearities in the relationship between spending and mortality….
How do we Get and Pay for New Antibiotics? Proposed New Models for Value Assessment and Contracting for Payment.
26 March 2020
…disease clinicians want to conserve new drugs for use in multi-drug resistant patients to preserve the effectiveness of these drugs for as long as possible). As a result, revenues are…
Cholesterol and Coronary Heart Disease: Consensus or Controversy?
1 March 1991
The severe expression of cardiovascular and particularly coronary heart disease in the UK is a proper cause for concern. Analysis of its associations clearly shows the multifactorial – some would…
Exploring Variations in the Opportunity Cost Cost-effectiveness Threshold by Clinical Area: Results from a Feasibility Study in England
1 March 2019
…allows the incorporation of multiple outcomes (not just mortality) and the measurement of efficiency and scale elasticity, while QR allows us to look for non-linearities in the relationship between spending…
Working Towards a Sustainable, Healthy Market for Vaccines: a Comprehensive Framework to Support Policy Dialogue and Decision-Making
1 September 2021
…policies that cut across multiple markets. It helps illustrate how challenges in the global vaccines market may be rooted in multiple factors across a market and how market-shaping interventions aimed…
Partnerships for Health System Innovation and Improvement
12 September 2023, 3:00pm
…adoption in health systems requires a breadth of solutions and the involvement of different stakeholder groups. Multistakeholder partnerships can remove silos, enhance knowledge exchange, conduct additional research on technology and…